Rankings
▼
Calendar
ACLX FY 2021 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena
ACLX
Arcellx, Inc.
$7B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$65M
Net Income
-$65M
EPS (Diluted)
$-1.94
Cash Flow
Operating Cash Flow
-$54M
Free Cash Flow
-$60M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$129M
Total Liabilities
$250M
Stockholders' Equity
-$122M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$65M
-$32M
-102.6%
Net Income
-$65M
-$32M
-102.4%
← Q4 2020
All Quarters
Q1 2021 →